FibroGen/AstraZeneca Novel Anemia Drug Approved in China — Before US/EU Approvals Dec 28, 2018 Life Science
China’s NMPA Approves Innovent’s Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin’s Lymphoma Dec 27, 2018 Life Science
Calif ornia-Based Opiant Licenses Synthetic Cannabinoid Overdose Drug From Sanofi for $500,000 Dec 27, 2018 Cannabis, Life Science
Rakuten Aspyrian Closes $284 Million Series C Financing for Late-Stage Oncology Pipeline Dec 24, 2018 Life Science
Xynomic Pharmaceuticals Picks up Second Cancer Drug From Boehringer Ingelheim in $800 Million Deal Dec 21, 2018 Life Science
Gan & Lee and a Leading Pharmaceutical Company Enters into Global Collaboration to Commercialize Insulin Analog Dec 21, 2018 Life Science
Chi-Med Announces Amendment to the 2013 License & Collaboration Agreement on Fruquintinib with Eli Lilly and Company Dec 20, 2018 Life Science
